22 Quotes by Steven Nissen

I do not think it's wise to approve the drug or see the drug marketed until there's a dedicated cardiovascular safety trial,

Getting rid of that plaque is a fundamental step in stopping this disease.

I expected the advisory panel to turn the drug down. When they didn't, I was really surprised. And so I now had a potential public health catastrophe in the waiting,

I expected the advisory panel to turn the drug down.

It could be that we've gotten LDL down as low as we can.

I think the FDA advisory committee was asleep at the switch, ... The question is, did they not get it, or did they get it and were not willing to stand their ground?

We can't just discuss future strategies, we need to discuss what needs to be done now about the risks and informing people about them. I think a black box is in order that could be removed if information is obtained that does not implicate the drugs.

We've desperately needed this. The entire public confidence in terms of what is safe for pain has been eroded.

When you have that kind of exposure to drugs that are suspicious, it creates a major public health concern.